Owen Hughes
Algemeen Directeur bij XOMA CORPORATION
Vermogen: 138 760 $ op 30-04-2024
Momenteel actieve connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Anthony Adam Rosenberg | M | 71 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 9 jaar |
George Martin | M | 65 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 9 jaar |
Nadim Ahmed | M | 56 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 3 jaar |
William Irving | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Mark Manfredi | M | 53 | 8 jaar | |
Jean-Francois Formela | M | 67 | 13 jaar | |
Kendra Adams | F | 48 | 4 jaar | |
Michael Jarasitis | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Steven Helwig | M | 51 | 9 jaar | |
Thomas Ebeling | M | 65 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Stephen Webster | M | 63 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 4 jaar |
Samuel Cohen | M | 38 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
Andrew Hirsch | M | 53 | 4 jaar | |
Andrew von Eschenbach | M | 82 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 5 jaar |
Kenneth Anderson | M | 72 | 9 jaar | |
Richard Wooster | M | 59 | 5 jaar | |
Jennifer Michaelson | M | 57 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 6 jaar |
Bihua Chen | F | 55 | 9 jaar | |
William Daniel | M | 72 | 9 jaar | |
Bruce Downey | M | 76 | 9 jaar | |
Jack Wyszomierski | M | 68 | 14 jaar | |
Corinne Savill | M | 64 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Maria Koehler | M | 67 | 3 jaar | |
Utpal Koppikar | M | 53 | 2 jaar | |
Chhaya Shah | F | 60 | 6 jaar | |
Malcolm Salter | M | 84 | 9 jaar | |
Michele Vendruscolo | F | 58 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
Christopher Dobson | M | 75 |
Wavebreak Therapeutics Ltd.
Wavebreak Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Wavebreak Therapeutics Ltd. operates as a biopharmaceutical company that focuses on drug discovery and subsequent clinical translation of molecules which will impact protein misfolding diseases. Its proprietary technology platform is built on new and fundamental understanding of the origins of these diseases and is based on decades of scientific research at the University of Cambridge and Lund University. The company was founded by Christopher Dobson, Michele Vendruscolo, and Tuomas Knowles on March 10, 2016 and is headquartered in Cambridge, the United Kingdom. | 8 jaar |
Jeffrey Ecsedy | M | 54 | 7 jaar | |
Laura Bessen | M | 61 | 2 jaar | |
Jolie Siegel | F | 47 | 4 jaar | |
Bruce Mitlak | M | - | 8 jaar | |
Heather Franklin | F | 58 | 3 jaar | |
Thomas Burns | M | 50 | 18 jaar | |
Jean-Michel Cossery | M | 65 | 6 jaar | |
Glenn Dubin | M | 67 | 3 jaar | |
Dan Tremblay | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Charles Ackerman | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 18 jaar |
Joseph Limber | M | 71 | 12 jaar | |
David Bonita | M | 48 | - | |
Otello Stampacchia | M | 55 | 4 jaar | |
Matthew Perry | M | 51 | 7 jaar | |
Mark Schmehl | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 17 jaar |
Barbara Kosacz | F | 66 | 5 jaar | |
Donna Grogan | M | 67 | 2 jaar | |
Iain Dukes | M | 65 | 8 jaar | |
Peter A. Schwartzman | M | - | 4 jaar | |
Rudy Mareel | M | 61 | 6 jaar | |
Natasha Hernday | F | 52 | 4 jaar | |
Joan Gray | F | - | 3 jaar | |
Stephanie Torruella | F | - | 4 jaar | |
Rohan Lathia | M | - | 3 jaar | |
Travis Wilson | M | - | 2 jaar | |
Salvador Grausso | M | 49 | 4 jaar | |
Laura Furmanski | F | - | 2 jaar | |
Cole Ikkala | M | - | 4 jaar | |
Rupert Haynes | M | - | 3 jaar | |
Jotin Marango | M | 45 | 2 jaar | |
Mark Mossler | M | 51 | 1 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Oude connecties
Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
---|---|---|---|---|
Ronald Renaud | M | 55 | 8 jaar | |
Ansbert Gadicke | M | 66 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 11 jaar |
Young Duchung Chin | M | - |
FIAM LLC
FIAM LLC Investment ManagersFinance FIAM LLC (do-business-as Fidelity Institutional Asset Management) is a SEC-registered investment advisor headquartered in Smithfield, Rhode Island. The firm was founded in 2006 and formerly known as Pyramis Global Advisors LLC. They are wholly-owned by FIAM Holdings LLC, which in turn is owned by FMR LLC, aka Fidelity Investments. FIAM provides discretionary investment management services to institutional accounts. They also sub-advice funds or accounts for affiliated advisers and unaffiliated advisers. | 7 jaar |
Raymond T. Keane | M | 65 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
Intarcia Therapeutics, Inc.
Intarcia Therapeutics, Inc. BiotechnologyHealth Technology Intarcia Therapeutics, Inc. develops therapies for the treatment of chronic diseases. Its lead product candidate, ITCA 650, is currently in development for the treatment of type 2 diabetes. The firm’s platform technology is a proprietary subcutaneous delivery system that involves a matchstick-size, miniature osmotic pump implanted sub-dermally to provide continuous and consistent drug therapy, and the company’s proprietary formulation technology, which maintains stability of therapeutic proteins and peptides at human body temperatures for long extended periods of time. The company was founded by Mark Moran in June 1995 and is headquartered in Boston, MA. | 9 jaar |
Patrick Baeuerle | M | 66 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
James Neal | M | 68 | 14 jaar | |
Daniel Dolan | M | 47 | 4 jaar | |
Michael Wyzga | M | 69 | 2 jaar | |
Jose Carmona | M | 51 | 3 jaar | |
James Chopas | M | 58 | 3 jaar | |
Jesper Høiland | M | 63 | 3 jaar | |
Jon Wigginton | M | 62 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 2 jaar |
Darragh Lyons | M | 43 | 8 jaar | |
Paul Burgess | M | 50 | 6 jaar | |
Mark Conley | M | 62 | 2 jaar | |
Michael Heartlein | M | 65 | 9 jaar | |
John R. Schroer | M | 58 | 2 jaar | |
Anderson Timothy | M | - |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 2 jaar |
Averi Price | F | - | 6 jaar | |
Adrian Howd | M | 52 | 3 jaar | |
Jeffrey Trigilio | M | 40 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 4 jaar |
Donal O'Connor | M | 73 | 1 jaar | |
Morana Jovan-Embiricos | M | 57 |
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | 7 jaar |
Andrew Fromkin | M | 58 | - | |
W. van Ness | M | 81 | 42 jaar | |
Erick Lucera | M | 57 |
Triathlon Fund Management LLC
Triathlon Fund Management LLC Investment ManagersFinance Triathlon Fund Management LLC is a hedge fund headquartered in Boston. | 3 jaar |
Brian Harvey | M | 63 | 11 jaar | |
Robert E. Ward | M | 66 | 4 jaar | |
Brent Hatzis-Schoch | M | 59 | 4 jaar | |
Kyran McLaughlin | M | 80 | 2 jaar | |
Robert Alexander Ingram | M | 81 | 3 jaar | |
Jonathan Fleming | M | 66 | 2 jaar | |
Jennifer Jarrett | F | 53 | - | |
Elhan Webb | F | - | - | |
Alan Auerbach | M | 54 | 6 jaar | |
Gary Hattersley | M | 57 | 15 jaar | |
Michael Franken | M | 59 | - | |
Kurt Graves | M | 56 | 9 jaar | |
Catherine Friedman | F | 63 | 7 jaar | |
Elizabeth Stoner | M | 73 | 4 jaar | |
Martin C. Münchbach | M | 54 | 4 jaar |
Statistieken
Land | Connecties | % van het totaal |
---|---|---|
Verenigde Staten | 89 | 89.00% |
Ierland | 9 | 9.00% |
Verenigd Koninkrijk | 5 | 5.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Owen Hughes
- Persoonlijk netwerk